Recent
Publications
Unger RH,
Cherrington AD (2012) Glucagonocentric restructuring of
diabetes: a pathophysiologic and therapeutic makeover J Clin Invest. 2012
Jan 3; 122 (1):4-12.
Chen L, Philippe J, Unger RH (2011)
Glucagon responses of isolated α cells to glucose,
insulin, somatostatin, and leptin. Endocr Pract. 2011
Sep 1;17(5):819-25.
Kruger, AJ, Yang, C, Lipson, KL, Pino, SC, Leif, JH,
Hogan, CM, Whalen, BJ, Guberski, DL, Unger, RH, Greiner,
DL, Rossini, AA, Bortell, R (2011) Leptin Treatment
Cofers Clinical Benefit at Multiple stages of Virally
Induced Type 1 Diabetes in BB Rats. Autoimmunity, 2011
Mar;44(2):137-48.
Lee Y, Wang MY, Du XQ,
Charron MJ, Unger RH.(2011)
Glucagon receptor knockout prevents insulin-deficient
type 1 diabetes in mice. Diabetes. 2011 Feb;60(2):391-7.
Yilmaz C, Ravikumar P, Bellotto DJ, Unger RH, Hsia
CC(2010) Fatty diabetic lung: functional impairment in a
model of metabolic syndrome. J Appl Physiol. 2010 Dec;109(6):1913-9.
Unger, RH and
Orci, L. (2010). The Paracrinology of Islets and the
Paracrinopathy of Diabetes. PNAS, Sep 14;107(37):16009-12
Unger, RH and
Scherer, PE (2010). Gluttony, Sloth, and the Metabolic
Syndrome: A Roadmap to Lipotoxicity. Trends in Endocrinology & Medicine,
Jun;21(6):345-52.
Wang, M-Y, Chen, L., Clark, G, Lee, Y, Stevens R,
Ilkayeva, O, Wenner B, Bain J, Charron M, Newgard, C, Unger, RH.
(2009) Leptin Therapy in insulin-deficient Type I
Diabetes. PNAS,
2010 Mar;107(11):4813-4819.
Vidal-Puig, A and Unger,
RH. Special issue on lipotoxicity (Guest
Editors). (2010). Biochim
Biophys Acta, 2010 Mar;1801(3):207-8.
Unger, RH, Clark,
GO, Orci, L., Scherer, P. (2010) Lipid Homeostasis,
Lipotoxicity and the Metabolic Syndrome. Biochim Biophys Acta.
2010 Mar;1801(3):209-14.